Search Results - "Shvachko, Valentina A"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Distribution of hepatitis C virus genotypes in a diverse US integrated health care population by Manos, M. Michele, Shvachko, Valentina A., Murphy, Rosemary C., Arduino, Jean Marie, Shire, Norah J.

    Published in Journal of medical virology (01-11-2012)
    “…Hepatitis C virus (HCV) genotypes influence response to therapy, and recently approved direct‐acting antivirals are genotype‐specific. Genotype distribution…”
    Get full text
    Journal Article
  3. 3

    Characteristics and Management of Patients with Chronic Hepatitis B in an Integrated Care Setting by Sarkar, Monika, Shvachko, Valentina A., Ready, Joanna B., Pauly, Mary Pat, Terrault, Norah A., Peters, Marion G., Manos, M. Michele

    Published in Digestive diseases and sciences (01-09-2014)
    “…Background Few population-based studies have described characteristics and management of patients with chronic hepatitis B (CHB) in the USA. Methods We…”
    Get full text
    Journal Article
  4. 4

    Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting by Price, Jennifer C., Murphy, Rosemary C., Shvachko, Valentina A., Pauly, Mary Pat, Manos, M. Michele

    Published in Digestive diseases and sciences (01-12-2014)
    “…Background In 2011, the FDA approved telaprevir (TVR) and boceprevir (BOC) for use with pegylated interferon and ribavirin to treat hepatitis C virus (HCV)…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Physical, Social, and Psychological Consequences of Treatment for Hepatitis C: A Community-Based Evaluation of Patient-Reported Outcomes by Manos, M. Michele, Ho, Chanda K., Murphy, Rosemary C., Shvachko, Valentina A.

    “…Background Hepatitis C virus (HCV) antiviral therapy entails a long treatment course, as well as significant side effects that can lead to medication…”
    Get full text
    Journal Article